EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Clinical mechanism of muscle mass loss during neoadjuvant chemotherapy in older patients with esophageal cancer: a prospective cohort study

Tsuyoshi Harada iD, Tetsuya Tsuji, Junya Ueno, Nobuko Konishi, Takumi Yanagisawa, Nanako HIjikata, Aiko Ishikawa, Kakeru Hashimoto, Hitoshi Kagaya, Noriatsu Tatematsu, Sadamoto Zenda, Daisuke Kotani und 2 weitere

Diseases of the Esophagus · 2025

DOI: 10.1093/dote/doae096 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Diseases of the Esophagus, 2025. Verfasst von Tsuyoshi Harada und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Neoadjuvant Therapy, Muscle, Skeletal, Sarcopenia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In older patients with locally advanced esophageal cancer (LAEC), loss of skeletal muscle mass during neoadjuvant chemotherapy (NAC) is associated with poor clinical outcomes. This study aimed to investigate factors associated with loss of skeletal muscle mass during NAC in older patients with LAEC. This was a single-center exploratory prospective cohort study. Consecutive patients aged ≥65 years with LAEC scheduled for curative esophagectomy after NAC were enrolled between October 2021 and December 2023. As a primary endpoint, loss of skeletal muscle mass index (ΔSMI: pre-NAC minus post-NAC value) was calculated from computed tomography images before and after NAC. Significant pre-NAC and during-NAC factors with ΔSMI were detected with a multivariate regression model. Statistical significance was considered as two-tailed P <0.05. A total of 69 patients were analyzed. The mean age was 72.9 years, and 53 (77%) were male. Mean SMI before and after NAC was 43.1 and 40.9 cm2/m2, and mean ΔSMI was 2.2 cm2/m2. In multivariate analysis, ΔSMI was associated with increased sitting time during NAC (per 1 min/day, adjusted coefficient 0.007, 95% confidence interval [CI] 0.001 to 0.013, P = 0.016), decreased Geriatric Nutritional Risk Index during NAC (per 1 score, adjusted coefficient −0.146, 95% CI −0.213 to −0.013, P = 0.002), and worsening decreased appetite during NAC (vs. no worsening, adjusted coefficient 1.571, 95% CI 0.279 to 2.862, P = 0.018). It was hypothesized that the inactivity-related mechanism and malnutrition-related mechanism are important for skeletal muscle mass loss during NAC in older patients with LAEC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsNeoadjuvant TherapyMuscle, SkeletalSarcopeniaEsophagectomyHumansAgedMaleFemaleProspective StudiesTomography, X-Ray ComputedAged, 80 and overChemotherapy, Adjuvant

Stichwörter der Autor:innen

chemotherapyesophageal cancergeriatricsnutritionrehabilitation

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Department of Rehabilitation Medicine, Keio University Graduate School, Shinjuku, Tokyo, Japan.
  • Department of Rehabilitation Medicine, Keio University School of Medicine, Shinjuku, Tokyo, Japan.
  • Department of Rehabilitation, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
  • Department of Integrated Health Sciences, Nagoya University, Nagoya, Aichi, Japan.
  • Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

ORCID-Profile: Tsuyoshi Harada

Zitieren

APA

Harada, T., Tsuji, T., Ueno, J., Konishi, N., Yanagisawa, T., HIjikata, N., Ishikawa, A., Hashimoto, K., Kagaya, H., Tatematsu, N., Zenda, S., Kotani, D., Kojima, T., & Fujita, T. (2025). Clinical mechanism of muscle mass loss during neoadjuvant chemotherapy in older patients with esophageal cancer: a prospective cohort study. Diseases of the Esophagus. https://doi.org/10.1093/dote/doae096

Vancouver

Harada T, Tsuji T, Ueno J, Konishi N, Yanagisawa T, HIjikata N, et al. Clinical mechanism of muscle mass loss during neoadjuvant chemotherapy in older patients with esophageal cancer: a prospective cohort study. Diseases of the Esophagus. 2025. doi:10.1093/dote/doae096

BibTeX
@article{Harada2025,
  author = {Harada, Tsuyoshi and Tsuji, Tetsuya and Ueno, Junya and Konishi, Nobuko and Yanagisawa, Takumi and HIjikata, Nanako and Ishikawa, Aiko and Hashimoto, Kakeru and Kagaya, Hitoshi and Tatematsu, Noriatsu and Zenda, Sadamoto and Kotani, Daisuke and Kojima, Takashi and Fujita, Takeo},
  title = {Clinical mechanism of muscle mass loss during neoadjuvant chemotherapy in older patients with esophageal cancer: a prospective cohort study},
  journal = {Diseases of the Esophagus},
  year = {2025},
  doi = {10.1093/dote/doae096}
}
Kostenlos starten →